Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Vernakalant IV	61
Overall Study	STARTED	Placebo	62
Overall Study	Discontinued Pre Dose	Vernakalant IV	6
Overall Study	Discontinued Pre Dose	Placebo	6
Overall Study	Dosed	Vernakalant IV	55
Overall Study	Dosed	Placebo	56
Overall Study	Discontinued Post Dose	Vernakalant IV	2
Overall Study	Discontinued Post Dose	Placebo	0
Overall Study	COMPLETED	Vernakalant IV	53
Overall Study	COMPLETED	Placebo	56
Overall Study	NOT COMPLETED	Vernakalant IV	8
Overall Study	NOT COMPLETED	Placebo	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01174160/flow